<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Behav. Neurosci.</journal-id>
<journal-title>Frontiers in Behavioral Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Behav. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5153</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnbeh.2017.00032</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Prefrontal Dopaminergic Mechanisms of Extinction in Adolescence Compared to Adulthood in Rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zbukvic</surname> <given-names>Isabel C.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/410970/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Park</surname> <given-names>Chun Hui J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/416339/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ganella</surname> <given-names>Despina E.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/105351/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Lawrence</surname> <given-names>Andrew J.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/29539/overview"/>
</contrib> 
<contrib contrib-type="author" corresp="yes">
<name><surname>Kim</surname> <given-names>Jee Hyun</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/61380/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Developmental Psychobiology Laboratory, Behavioral Neuroscience Division, The Florey Institute of Neuroscience and Mental Health</institution> <country>Parkville, VIC, Australia</country></aff>
<aff id="aff2"><sup>2</sup><institution>Developmental Psychobiology Laboratory, The Florey Department of Neuroscience and Mental Health, University of Melbourne</institution> <country>Parkville, VIC, Australia</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Johannes Gr&#x000E4;ff, &#x000C9;cole Polytechnique F&#x000E9;d&#x000E9;rale de Lausanne (EPFL), Switzerland</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Seth Davin Norrholm, Emory University School of Medicine, USA; Walter Adriani, Istituto Superiore di Sanit&#x000E0;, Italy</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Jee Hyun Kim <email>drjeehyunkim&#x00040;gmail.com</email></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>22</day>
<month>02</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>11</volume>
<elocation-id>32</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>02</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Zbukvic, Park, Ganella, Lawrence and Kim.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Zbukvic, Park, Ganella, Lawrence and Kim</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract><p>Adolescents with anxiety disorders attain poorer outcomes following extinction-based treatment compared to adults. Extinction deficit during adolescence has been identified to involve immaturity in the medial prefrontal cortex (mPFC). Findings from adult rodents suggest extinction involves dopamine signaling in the mPFC. This system changes dramatically during adolescence, but its role in adolescent extinction is unknown. Therefore, we investigated the role of prefrontal dopamine in extinction using Pavlovian fear conditioning in adolescent and adult rats. Using quantitative PCR (qPCR) analyses, we measured changes in dopamine receptor gene expression in the mPFC before and after extinction. We then enhanced dopamine 1 receptor (D1R) or dopamine 2 receptor (D2R) signaling in the infralimbic cortex (IL) of the mPFC using agonists at the time of extinction. Adolescent rats displayed a deficit in extinction retention compared to adults. Extinction induced a reduction in D1R compared to D2R gene expression in adolescent rats, whereas an increase of D1R compared to D2R gene expression was observed in adult rats. Acutely enhancing IL D1R signaling using SKF-81297 had no effect on extinction at either age. In contrast, acutely enhancing IL D2R signaling with quinpirole significantly enhanced long-term extinction in adolescents, and impaired within-session extinction in adults. Our results suggest a dissociated role for prefrontal dopamine in fear extinction during adolescence compared to adulthood. Findings highlight the dopamine system as a potential pharmacological target to improve extinction-based treatments for adolescents.</p></abstract>
<kwd-group>
<kwd>extinction</kwd>
<kwd>fear</kwd>
<kwd>adolescence</kwd>
<kwd>dopamine</kwd>
<kwd>prefrontal cortex</kwd>
<kwd>conditioning</kwd>
</kwd-group>
<contract-num rid="cn001">APP1083309</contract-num>
<contract-num rid="cn001">APP1020737</contract-num>
<contract-sponsor id="cn001">National Health and Medical Research Council<named-content content-type="fundref-id">10.13039/501100000925</named-content></contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="87"/>
<page-count count="11"/>
<word-count count="9087"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="introduction" id="s1">
<title>Introduction</title>
<p>Anxiety disorders are the most frequent mental illness experienced by adolescents worldwide (Polanczyk et al., <xref ref-type="bibr" rid="B67">2015</xref>). Exposure therapy for anxiety is based on the principle of extinction, in which fear to a stimulus can be reduced by repeated presentations of that stimulus without an aversive outcome. Adolescents attain poorer outcomes following exposure therapy for anxiety compared with children (Southam-Gerow et al., <xref ref-type="bibr" rid="B78">2001</xref>; Bodden et al., <xref ref-type="bibr" rid="B11">2008</xref>). Consistent with this, studies in humans and rodents showed that extinction is impaired in adolescents compared to adults and juveniles/children (Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>; Pattwell et al., <xref ref-type="bibr" rid="B62">2012</xref>; Baker and Richardson, <xref ref-type="bibr" rid="B9">2015</xref>). Specifically, extinction memory is &#x0201C;forgotten&#x0201D; in adolescent rodents that show high freezing when tested in the same context as extinction, compared to adult rodents. It has therefore been suggested that adolescent resistance to exposure-based therapies relates to deficits in extinction learning at this age (Hartley and Casey, <xref ref-type="bibr" rid="B28">2013</xref>; Kim and Ganella, <xref ref-type="bibr" rid="B39">2015</xref>).</p>
<p>The prefrontal cortex (PFC) is a critical neural region underlying extinction deficits in adolescent rodents (Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>; Pattwell et al., <xref ref-type="bibr" rid="B62">2012</xref>; Baker and Richardson, <xref ref-type="bibr" rid="B9">2015</xref>). This is not surprising, as the PFC, especially the infralimbic cortex (IL), has repeatedly been identified to be particularly important for the recall of extinction across different learning paradigms and different ages (Quirk et al., <xref ref-type="bibr" rid="B70">2000</xref>; Laurent and Westbrook, <xref ref-type="bibr" rid="B45">2008</xref>; Peters et al., <xref ref-type="bibr" rid="B65">2009</xref>; Mueller et al., <xref ref-type="bibr" rid="B56">2010</xref>; Orsini et al., <xref ref-type="bibr" rid="B60">2011</xref>; Sierra-Mercado et al., <xref ref-type="bibr" rid="B76">2011</xref>; Gass and Chandler, <xref ref-type="bibr" rid="B25">2013</xref>; Abraham et al., <xref ref-type="bibr" rid="B1">2014</xref>). To further understand adolescent vulnerability to anxiety disorders, we aim to explore the role of prefrontal dopamine 1 receptor (D1R) and dopamine 2 receptor (D2R) in fear extinction during adolescence compared to adulthood. Dopamine signaling displays a unique maturation profile during adolescence, over and above many other neurotransmitter systems in the PFC (O&#x02019;Donnell, <xref ref-type="bibr" rid="B59">2010</xref>; Wahlstrom et al., <xref ref-type="bibr" rid="B85">2010</xref>; Kim et al., <xref ref-type="bibr" rid="B43">2016</xref>). The density of dopaminergic fiber infiltration of the PFC increases throughout adolescence until early adulthood in rodents (Kalsbeek et al., <xref ref-type="bibr" rid="B36">1988</xref>) and non-human primates (Rosenberg and Lewis, <xref ref-type="bibr" rid="B71">1995</xref>). Dopamine synthesis also peaks in the PFC during adolescence (Andersen et al., <xref ref-type="bibr" rid="B5">1997</xref>), along with dopamine receptor density in the PFC (Tarazi and Baldessarini, <xref ref-type="bibr" rid="B80">2000</xref>). Importantly, age-related discontinuities in the function of the dopamine system have been suggested to underlie the adolescent behavioral phenotype observed across human and non-human mammals (Laviola et al., <xref ref-type="bibr" rid="B47">2003</xref>). This includes differences in impulsivity and cue reactivity, behavioral responses critically implicated in extinction learning (Laviola et al., <xref ref-type="bibr" rid="B47">2003</xref>; Pattwell et al., <xref ref-type="bibr" rid="B61">2013</xref>).</p>
<p>Dopamine exerts its effects via five distinct receptors, which are subdivided into two families: D1-like and D2-like receptors (Andersen et al., <xref ref-type="bibr" rid="B4">1990</xref>). The D1-like subfamily comprises D1R and D5R, and the D2-like includes D2R, D3R and D4R (Missale et al., <xref ref-type="bibr" rid="B55">1998</xref>). The most abundant dopamine receptor subtypes in the central nervous system are D1R and D2R (Jaber et al., <xref ref-type="bibr" rid="B33">1996</xref>), with both showing expression in the medial prefrontal cortex (mPFC; Vincent et al., <xref ref-type="bibr" rid="B84">1993</xref>). As members of different subfamilies, D1R and D2R show distinct profiles in terms of downstream signal transduction and physiological effects (Jackson and Westlind-Danielsson, <xref ref-type="bibr" rid="B34">1994</xref>; Beaulieu and Gainetdinov, <xref ref-type="bibr" rid="B10">2011</xref>).</p>
<p>Findings in adult rats show complex involvement of prefrontal D1R and D2R signaling in fear extinction. For example, infusion of the D1R antagonist SCH-23390 into the IL of PFC impairs long-term fear extinction (Hikind and Maroun, <xref ref-type="bibr" rid="B29">2008</xref>). Consistent with this, transgenic mice lacking D1R show normal fear conditioning but delayed extinction up to 90 days post-conditioning (El-Ghundi et al., <xref ref-type="bibr" rid="B17">2001</xref>). By comparison, the role of D2R signaling in extinction is less clear. For instance, one study showed that pre-extinction systemic treatment with the D2R agonist quinpirole blocked extinction of conditioned fear (Nader and LeDoux, <xref ref-type="bibr" rid="B58">1999</xref>), while another showed largely no effect across a range of doses (0.25, 0.5, 2.0 mg/kg), though one dose (1.0 mg/kg) impaired long-term extinction (Ponnusamy et al., <xref ref-type="bibr" rid="B68">2005</xref>). However, pre-extinction systemic or intracerebroventricular (i.c.v.) injection of the D2R antagonist haloperidol has also been found to increase conditioned stimulus (CS)-elicited freezing during extinction and at test the next day (Holtzman-Assif et al., <xref ref-type="bibr" rid="B31">2010</xref>). However, systemic D2R antagonism with sulpiride facilitates extinction both within-session and at test the next day (Ponnusamy et al., <xref ref-type="bibr" rid="B68">2005</xref>), while one known study investigating intra-IL D2R antagonism using raclopride found impaired long-term fear extinction in adult rats the next day (Mueller et al., <xref ref-type="bibr" rid="B56">2010</xref>).</p>
<p>Interestingly, findings on the expression of D1R and D2R in the PFC across adolescence are also varied. For example, D1R and D2R density in the PFC has been reported to be high at postnatal day (P) 40, then decline into adulthood across P60, P80, P100 and P120, with D1R declining more dramatically compared to D2R (Andersen et al., <xref ref-type="bibr" rid="B6">2000</xref>). This is consistent with positron emission tomography (PET) findings in humans age 10&#x02013;30 years, which show that D1R binding in the PFC decreases from adolescence into adulthood (Jucaite et al., <xref ref-type="bibr" rid="B35">2010</xref>). Another human study reports a peak in D1R gene expression during adolescence compared to infancy and adulthood, with no changes in D2R gene expression across those ages (Weickert et al., <xref ref-type="bibr" rid="B86">2007</xref>). In contrast, studies have also found no change in D1R gene expression or binding in PFC from P21 to P60 in rodents (Leslie et al., <xref ref-type="bibr" rid="B48">1991</xref>; Tarazi et al., <xref ref-type="bibr" rid="B82">1999</xref>; Tarazi and Baldessarini, <xref ref-type="bibr" rid="B80">2000</xref>; Araki et al., <xref ref-type="bibr" rid="B7">2007</xref>). A human study found no significant difference in PFC D1R gene expression between adolescents and adults (Rothmond et al., <xref ref-type="bibr" rid="B72">2012</xref>). A study that used microarrays showed no changes relating to dopamine signaling, including D1R and D2R expression, across subjects aged 0&#x02013;49 years (Harris et al., <xref ref-type="bibr" rid="B27">2009</xref>). Taken together, further investigation into the changes in PFC D1R and D2R expression in adolescence and adulthood appear warranted, especially in light of the emerging role of PFC dopamine signaling in fear extinction.</p>
<p>To investigate the role of prefrontal dopamine signaling in adolescent vs. adult extinction, we first examined fear conditioning and extinction in adolescent and adult rats. Using real-time quantitative PCR (qPCR) analyses, we then measured extinction-related changes in mPFC D1R and D2R gene expression in adolescent and adult rats. Building on these results, we then acutely enhanced D1R or D2R signaling in IL during extinction using SKF-81297 or quinpirole, respectively. Dopamine receptor agonists were chosen so that parallels can be made to existing FDA-approved dopamine receptor agonists, which are more readily administered compared to dopamine receptor antagonists in adolescent humans (Kirino, <xref ref-type="bibr" rid="B44">2012</xref>; Kim and Lawrence, <xref ref-type="bibr" rid="B40">2014</xref>). Thus, results from the present chapter have strong translational potential for improving extinction-based treatments for anxiety, as well as adding to literature on the mechanisms of extinction across development.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Animals</title>
<p>Male Sprague-Dawley rats (<italic>N</italic> = 142) were bred in-house at the Florey Institute of Neuroscience and Mental Health. Rats were housed 2&#x02013;4 per cage in individually ventilated cages, maintained on a 12-h light/dark cycle (lights on at 7 a.m.) with food and water available <italic>ad libitum</italic>. Rats were handled daily for 3 days prior to the commencement of behavioral experiments. Rats were P(postnatal day)35 (&#x000B1;1) or P88 (&#x000B1;1) on extinction day (those ages fall within adolescence and adulthood, respectively, Madsen and Kim, <xref ref-type="bibr" rid="B51">2016</xref>). All procedures were approved by the Florey Animal Ethics Committee and performed in accordance with the guidelines of the National Health and Medical Research Council Code of Practice for the Care and Use of Animals for Experimental Purposes in Australia.</p>
</sec>
<sec id="s2-2">
<title>Surgery</title>
<p>For intracranial infusion experiments, a double guide cannula (26 gauge, PlasticsOne) bilaterally targeting the IL (AP, +3.0 mm; ML &#x000B1; 0.6 mm; DV &#x02212;4.6 mm [age P88] or &#x02212;4.2 mm [age P35]) was implanted stereotaxically (David Kopf Instruments, Tujunga, CA, USA). These coordinates were identified by pilot surgeries involving ink microinfusions using the rat brain atlas (Paxinos and Watson, <xref ref-type="bibr" rid="B64">1998</xref>). Rats were anesthetized with isoflurane (2%&#x02013;5% v/v) vaporized with oxygen and injected with meloxicam (3 mg/kg, i.p.). The cannula was secured to the skull using dental cement (Vertex, MA, USA) combined with anchoring screws (PlasticsOne, Roanoke, VA, USA). Obturators extending 1 mm below the guide cannula were inserted and covered with a metal cap. Rats received antibiotic (Baytril, Bayer Corporation; 10 mg/kg, i.p.) daily for 3 days following surgery. Obturators were checked and rats were weighed daily for 3&#x02013;5 days after surgery until behavioral experimentation.</p>
</sec>
<sec id="s2-3">
<title>Drugs</title>
<p>The bilateral infusion (0.5 &#x003BC;L/hemisphere) consisted of either vehicle (saline), SKF-81297 (dissolved in saline; 0.1 &#x003BC;g/hemisphere; Sapphire Bioscience, Redfern, NSW, Australia), or quinpirole (dissolved in saline; 1 &#x003BC;g/hemisphere; Tocris, UK) into the IL over 2 min. These doses were chosen based on previous studies that showed consistent effects specifically with these doses (Floresco and Phillips, <xref ref-type="bibr" rid="B18">2001</xref>; Floresco et al., <xref ref-type="bibr" rid="B19">2006</xref>; Lauzon et al., <xref ref-type="bibr" rid="B46">2009</xref>; Zbukvic et al., <xref ref-type="bibr" rid="B88">2016</xref>). The infusion cannula extended 1 mm below the guide cannula, and remained in place for 2 min following the infusion, and then rats underwent extinction. At the end of experimentation, cannula placements were validated by an experimenter who was blind to subject treatment. To visualize cannula placement, fresh frozen brains were sectioned and stained with cresyl violet (Kim et al., <xref ref-type="bibr" rid="B38">2009</xref>).</p>
</sec>
<sec id="s2-4">
<title>Procedures</title>
<p>All behavioral sessions used standard fear conditioning chambers (31.8 &#x000D7; 25.4 &#x000D7; 26.7 cm, Med Associates, St. Albans City, VT, USA), using previously published protocol (Ganella et al., <xref ref-type="bibr" rid="B22">2016</xref>). A grid floor consisting of 4.8 mm stainless steel rods set 16 mm apart allowed delivery of an electric footshock, which served as the unconditioned stimulus (US). A speaker positioned in one wall of each chamber was used to produce a tone (5000 Hz, 80 dB), which served as the the conditioned stimulus (CS). Chambers were housed in cabinets insulated with acoustical soundproof foam to minimize external noise. A ventilation fan in each cabinet produced low-level constant background noise. Chambers contained a near infra-red (NIR) fear conditioning system and a monochrome video camera equipped with 8.0 mm lens and NIR pass filter was attached to the inside of each cubicle to record behavior. Freezing behavior was quantified using VideoFreeze software (Med Associates, St. Albans City, VT, USA), which shows high concordance with manual scoring as previously described (Ganella et al., <xref ref-type="bibr" rid="B22">2016</xref>). Fear was measured by levels of freezing behavior, defined as a motion threshold of less than 50 pixels for a minimum of 1 s duration. All CS and US presentations were controlled and recorded by VideoFreeze software (Med Associates, St. Albans City, VT, USA).</p>
<p>Two separate rooms representing two different experimental contexts housed four conditioning chambers each, to administer extinction and test in a different context to conditioning as described previously in other studies examining fear extinction during adolescence (McCallum et al., <xref ref-type="bibr" rid="B52">2010</xref>; Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>). This design is widely employed across fear extinction studies, to isolate extinction learning of the conditioned cue separate from the conditioned context (Mueller et al., <xref ref-type="bibr" rid="B57">2009</xref>; Holmes and Quirk, <xref ref-type="bibr" rid="B30">2010</xref>; Ganella et al., <xref ref-type="bibr" rid="B22">2016</xref>).</p>
<p>In one context, the back wall of the chambers was covered with a plastic spot-patterned cover and a tray containing woodchip bedding was located underneath the grid floor. In this context, chambers were cleaned with eucalyptus-scented disinfectant before each session and a white houselight remained on in each chamber for the duration of all sessions. In the other context, chambers were fitted with a curved white wall that covered the sides and back walls of the chamber, trays beneath the grid floor contained paper towel, and houselights were off for the duration of all sessions and a red light was on in the room. Chambers in this context were cleaned with ethanol (80% v/v in water) before each session. The two contexts served as conditioning or extinction/test contexts in a counterbalanced manner.</p>
<sec id="s2-4-1">
<title>Conditioning</title>
<p>On day 1 of behavioral experimentation, rats were placed in the chambers and their baseline level of freezing was recorded for 2 min. The CS tone (80 dB) was then presented for 10 s and co-terminated with a 1 s footshock (0.6 mA). There were three CS-US pairings and the inter-trial interval (ITI) between each pairing was between 85&#x02013;135 s. Following the last CS-US pairing, rats remained in the chambers for 2 min before returning to their home cages.</p>
</sec>
<sec id="s2-4-2">
<title>Extinction</title>
<p>On day 2, rats received extinction in the context different to that in which conditioning took place. Baseline freezing was measured for the first 2 min, followed by 30 CS alone trials with a 10 s ITI.</p>
</sec>
<sec id="s2-4-3">
<title>Test</title>
<p>On day 3, rats were tested in the same context as extinction. Baseline freezing was measured for the first minute, followed by a 2 min presentation of the CS alone. Rats remained in the chambers for 1 min before returning to their home cages.</p>
</sec>
</sec>
<sec id="s2-5">
<title>Gene Expression Analysis</title>
<p>For the gene expression experiment the Pre-extinction group did not receive extinction but were handled for 2 min by the experimenter. The Post-extinction group underwent extinction as described. Rats were deeply anesthetized by sodium pentobarbitone injection (100 mg/kg, i.p.) 2 h following handling (Pre-extinction) or extinction (Post-extinction). Previously published protocol was used to measure mRNA levels (Chen et al., <xref ref-type="bibr" rid="B16">2016</xref>). Specifically, brains were rapidly removed and sectioned using a brain matrix (<italic>World Precision Instruments</italic>, Sarasota, FL, USA) under RNase-free conditions. The mPFC was micro-dissected (Figure <xref ref-type="fig" rid="F1"></xref><xref ref-type="fig" rid="F2">2C</xref>), and tissue was snap frozen over liquid nitrogen then stored at &#x02212;80&#x000B0;C.</p>
<p>Total RNA was extracted from the mPFC from both hemispheres using an RNeasy Mini kit (Qiagen, Malvern East, VIC, Australia), then reverse transcribed into cDNA using TaqMan Reverse Transcription reagents as per the manufacturer&#x02019;s protocol (Applied Biosystems). Gene expression was analyzed by qPCR using SYBR Green Mastermix (Applied Biosystems) on a ViiA<sup>TM</sup> 7 Real-Time PCR System (ThermoFisher Scientific). Three housekeeping genes (<italic>Actb</italic>, <italic>Gapdh</italic> and <italic>Hprt1</italic>) were assessed for stability in adult and adolescent mPFC. <italic>Hprt1</italic> was the least variable between groups and was used for all subsequent analyses. Primers were designed using Primer3 (Rozen and Skaletsky, <xref ref-type="bibr" rid="B73">2000</xref>) as follows:</p>
<p><italic>Hprt1</italic>&#x000A0;&#x000A0;&#x000A0;forward&#x000A0;&#x000A0;&#x000A0;5&#x02032;-CTGGTGAAAAGGACCTCTCG-3&#x02032;; <italic>Hprt1</italic>&#x000A0;&#x000A0;&#x000A0;reverse&#x000A0;&#x000A0;&#x000A0;5&#x02032;-TCCACTTTCGCTGATGACAC-3&#x02032;, <italic>Drd1</italic>&#x000A0;&#x000A0;&#x000A0;forward&#x000A0;&#x000A0;&#x000A0;5&#x02032;-CCTTCGATGTGTTTGTGTGG-3&#x02032;, <italic>Drd1</italic>&#x000A0;&#x000A0;&#x000A0;reverse&#x000A0;&#x000A0;&#x000A0;5&#x02032;-GGGCAGAGTCTGTAGCATCC-3&#x02032;; <italic>Drd2</italic>&#x000A0;&#x000A0;&#x000A0;forward&#x000A0;&#x000A0;&#x000A0;5&#x02032;-TCCTGTCCTTCACCATCTCC-3&#x02032;, <italic>Drd2</italic>&#x000A0;&#x000A0;&#x000A0;reverse&#x000A0;&#x000A0;&#x000A0;5&#x02032;-GACCAGCAGAGTGACGATGA-3&#x02032;.</p>
<p>Data were interpreted using 2<sup>&#x02212;&#x00394;CT</sup> and 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> methods (Livak and Schmittgen, <xref ref-type="bibr" rid="B50">2001</xref>). To compare gene expression between age groups at Pre-extinction, the 2<sup>&#x02212;&#x00394;CT</sup> method was used. To examine change in gene expression between Pre-extinction and Post-extinction groups, the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method was used. Because prefrontal neural networks are governed by a balance of D1R vs. D2R signaling (Seamans and Yang, <xref ref-type="bibr" rid="B74">2004</xref>), gene expression was also analyzed as a ratio using 2<sup>&#x02212;&#x00394;CT</sup>D1R/D2R (&#x00394;CT<sub>D1R/D2R</sub> = CT<sub>D1R</sub>&#x02212;CT<sub>D2R</sub>) and 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> (&#x00394;&#x00394;CT<sub>D1R/D2R</sub> = &#x00394;CT<sub>D1R/D2R</sub>&#x02212;(CT<sub>D1R average Pre-extinction</sub> &#x02212; CT<sub>D2R average Pre-extinction</sub>)).</p>
</sec>
<sec id="s2-6">
<title>Data Analysis and Baseline Levels of Freezing</title>
<p>Statistical tests were conducted using SPSS (IBM Corp., New York, NY, USA), with acceptance for significance at <italic>p</italic> &#x02264; 0.05. Data were analyzed using one-way or repeated-measures analysis of variance (ANOVA; Tukey HSD multiple comparisons) appropriate to each experimental design. For analyses of within-session extinction, data were collapsed into six blocks of five CS presentations per block (Extinction blocks). Significant interactions were followed by <italic>post hoc</italic> per factor ANOVA (Tukey HSD multiple comparisons), or <italic>t</italic>-tests (when only two groups were in a factor) as described previously (Kim and Richardson, <xref ref-type="bibr" rid="B41">2010</xref>; Ganella et al., <xref ref-type="bibr" rid="B22">2016</xref>).</p>
<p>Analyses of baseline freezing for the first experiment showed no effect of age at conditioning, extinction or test. For the second experiment, there was no age effect on baseline at conditioning. There was an effect of age at extinction, however RM ANCOVA revealed that when baseline was controlled for, there was no effect of age on freezing during extinction. There was no effect of age on baseline at test. There was no effect in baseline freezing at any phase of the final experiment (<italic>p</italic>s &#x0003E; 0.05).</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Adolescents Display Extinction Deficits Compared to Adults</title>
<p>The first experiment aimed to elucidate behavioral differences in fear extinction across adolescence (Figure <xref ref-type="fig" rid="F1">1</xref>). Adolescent (<italic>n</italic> = 11) and adult (<italic>n</italic> = 13) rats were conditioned with three trials of tone (CS) paired with an electric footshock (US). CS-elicited freezing during conditioning was similar across age groups (Figure <xref ref-type="fig" rid="F1">1A</xref>). RM ANOVA showed a significant effect of conditioning trial (<italic>F</italic><sub>(2,44)</sub> = 23.9, <italic>p</italic> &#x0003C; 0.05), with no effect of age (<italic>F</italic><sub>(1,22)</sub> = 2.1, <italic>p</italic> = 0.2) and no interaction (<italic>F</italic><sub>(6,44)</sub> = 1.9, <italic>p</italic> = 0.2). The next day, rats received extinction training consisting of 30 CS-alone trials. Both age groups showed initial high levels of freezing to the CS that decreased over the 30 CS-alone trials (Figure <xref ref-type="fig" rid="F1">1B</xref>). RM ANOVA showed a significant effect of extinction block (<italic>F</italic><sub>(5,110)</sub> = 30.1, <italic>p</italic> &#x0003C; 0.05), with no effect of age (<italic>F</italic> &#x0003C; 1) and no interaction (<italic>F</italic><sub>(5,110)</sub> = 1.6, <italic>p</italic> = 0.2). Adolescents reinstated CS-elicited freezing when tested the next day, whereas adults did not (Figure <xref ref-type="fig" rid="F1">1C</xref>). RM ANOVA of the final block of extinction compared to test revealed a significant overall effect of day (<italic>F</italic><sub>(1,22)</sub> = 6.1, <italic>p</italic> &#x0003C; 0.05), and a significant interaction between day and age (<italic>F</italic><sub>(1,22)</sub> = 9.9, <italic>p</italic> &#x0003C; 0.05), with no effect of age (<italic>F</italic> &#x0003C; 1). <italic>Post hoc</italic> tests found a significant difference in freezing levels at extinction vs. test for adolescents (<italic>t</italic><sub>(10)</sub> = 3.0, <italic>p</italic> &#x0003C; 0.05), but not for adults (<italic>t</italic> &#x0003C; 1). Together, these findings indicate that long-term extinction is age-related, with adolescent rats displaying impaired extinction compared to adults.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Long-term extinction was impaired in adolescent rats compared to adult rats despite comparable within-session extinction.</bold> Adolescents <italic>n</italic> = 11, adults <italic>n</italic> = 13. <bold>(A)</bold> Adolescents and adults showed comparable conditioned stimulus (CS)-elicited freezing during fear conditioning. <bold>(B)</bold> Adolescent and adult rats showed a similar decrease in CS-elicited freezing over extinction. <bold>(C)</bold> Adolescents reinstated CS-elicited freezing 24 h after extinction training, characteristic of a deficit in long-term extinction at this age. Adult rats maintained low levels of CS-elicited freezing when tested 24 h after extinction training. Data represent mean &#x000B1; SEM. *<italic>p</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fnbeh-11-00032-g0001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Age Differences in mPFC Dopamine Receptor Gene Expression before and after Extinction</title>
<p>We then measured changes in prefrontal D1R vs. D2R gene expression pre- or post-extinction (Figure <xref ref-type="fig" rid="F2">2</xref>). Adolescent (<italic>n</italic> = 8) and adult (<italic>n</italic> = 12) rats received conditioning as described in the first experiment. All rats showed a significant increase in CS-elicited freezing during conditioning, however, the overall freezing levels were different between age groups (Figure <xref ref-type="fig" rid="F2">2A</xref>). RM ANOVA revealed an effect of conditioning trial (<italic>F</italic><sub>(2,36)</sub> = 34.4, <italic>p</italic> &#x0003C; 0.05) and an effect of age (<italic>F</italic><sub>(1,18)</sub> = 6.4, <italic>p</italic> = 0.02), but no interaction (<italic>F</italic><sub>(2,36)</sub> = 2.1, <italic>p</italic> = 0.1). Twenty-four hours after fear conditioning, half the rats were handled for 2 min without exposure to behavioral chambers (Pre-extinction). Remaining animals underwent extinction as per the first experiment (Post-extinction). Tissue was collected 2 h later. Adolescent and adult rats that received extinction showed comparable within-session extinction (Figure <xref ref-type="fig" rid="F2">2B</xref>). RM ANCOVA revealed that when baseline freezing was controlled for, there was an overall effect of extinction block (<italic>F</italic><sub>(5,35)</sub> = 3.4, <italic>p</italic> &#x0003C; 0.05), with no effect of age (<italic>F</italic><sub>(1,7)</sub> = 1.2, <italic>p</italic> = 0.3), and no effect of baseline (<italic>F</italic><sub>(1,7)</sub> = 2.7, <italic>p</italic> = 0.1). These results were the same with RM ANOVA.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Prefrontal dopamine receptor gene expression differed for adolescent and adult rats before and after extinction.</bold> Adolescents <italic>n</italic> = 8, adults <italic>n</italic> = 12. <bold>(A)</bold> Adolescents and adults showed an increase in CS-elicited freezing over repeated pairings of the CS (tone) and the unconditioned stimulus (US; foot shock). <bold>(B)</bold> Adolescents and adults that received extinction training showed a similar decrease in within-session CS-elicited freezing. <bold>(C)</bold> Coronal section illustrating medial prefrontal cortex (mPFC) collected for quantitative PCR (qPCR) analyses. Section within broken line indicates microdissected tissue. <bold>(D)</bold> Pre-extinction prefrontal dopamine 1 receptor (D1R) gene expression was higher in adolescents compared to adults. <bold>(E)</bold> There were no differences in prefrontal dopamine 2 receptor (D2R) gene expression prior to extinction. <bold>(F)</bold> Pre-extinction prefrontal D1R/D2R ratio was higher in adolescents compared to adults. <bold>(G)</bold> There were no changes in prefrontal D1R or <bold>(H)</bold> D2R gene expression following extinction, however <bold>(I)</bold> D1R/D2R ratio was significantly downregulated in adolescents and upregulated in adults following extinction. Data represent mean &#x000B1; SEM. *<italic>p</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fnbeh-11-00032-g0002.tif"/>
</fig>
<p>Adolescents showed higher prefrontal D1R mRNA expression than adults pre-extinction (<italic>t</italic><sub>(8)</sub> = 3.1, <italic>p</italic> &#x0003C; 0.05; Figure <xref ref-type="fig" rid="F2">2D</xref>). There was no age difference for D2R mRNA expression (<italic>t</italic> &#x0003C; 1; Figure <xref ref-type="fig" rid="F2">2E</xref>), however adolescents displayed a significantly higher D1R/D2R ratio than adults (<italic>t</italic><sub>(8)</sub> = 5.7, <italic>p</italic> &#x0003C; 0.05; Figure <xref ref-type="fig" rid="F2">2F</xref>).</p>
<p>There was no change in D1R mRNA expression at post-extinction relative to pre-extinction for either age, with ANOVA showing no effect of treatment (<italic>F</italic> &#x0003C; 1), no effect of age (<italic>F</italic><sub>(1,16)</sub> = 2.4, <italic>p</italic> = 0.1) and no interaction (<italic>F</italic><sub>(1,16)</sub> = 1.1, <italic>p</italic> = 0.3; Figure <xref ref-type="fig" rid="F2">2G</xref>). There was also no change in D2R mRNA expression at post-extinction compared to pre-extinction for either age, with ANOVA showing no effect of treatment, age and no interaction (<italic>F</italic>s &#x0003C; 1; Figure <xref ref-type="fig" rid="F2">2H</xref>). However, there was a significant difference in D1R/D2R mRNA ratio at post-extinction relative to pre-extinction for each age. ANOVA showed a significant effect of age (<italic>F</italic><sub>(1,16)</sub> = 9.4, <italic>p</italic> &#x0003C; 0.05) and a significant interaction between treatment and age (<italic>F</italic><sub>(1,16)</sub> = 8.5, <italic>p</italic> &#x0003C; 0.05), and no effect of treatment (<italic>F</italic><sub>(1,16)</sub> = 0.3, <italic>p</italic> = 0.6). <italic>Post hoc</italic> tests found that adolescent D1R/D2R mRNA ratio was significantly decreased following extinction (<italic>t</italic><sub>(6)</sub> = 2.6, <italic>p</italic> &#x0003C; 0.05), while adult D1R/D2R mRNA ratio was significantly increased (<italic>t</italic><sub>(10)</sub> = 2.3, <italic>p</italic> &#x0003C; 0.05; Figure <xref ref-type="fig" rid="F2">2I</xref>). These results suggest an age difference in prefrontal D1R/D2R mRNA ratio before fear extinction, driven by increased D1R mRNA expression in adolescent rats. Notably, D1R/D2R mRNA ratio changes in the opposite direction following extinction in adolescent or adult rats.</p>
</sec>
<sec id="s3-3">
<title>Enhancing IL D2R Signaling Facilitates Long-Term Extinction in Adolescents but Not Adults</title>
<p>We observed that prefrontal dopamine receptor gene expression is modulated in opposite directions following fear extinction in adolescence vs. adulthood. In order to investigate potential functional implications, we administered D1R or D2R agonist into the IL of the mPFC (Figure <xref ref-type="fig" rid="F3">3A</xref>), a brain region strongly implicated in adolescent deficit of extinction (Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>; Pattwell et al., <xref ref-type="bibr" rid="B62">2012</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p><bold>Intra-infralimbic cortex (IL) infusions of a D1R agonist (SKF-81297) or a D2R agonist (quinpirole) had different effects on within-session and long-term extinction for adolescent and adult rats. (A)</bold> Coronal sections illustrating intracranial cannula placements in adolescents (left) and adults (right). Bilateral cannula targeted the IL. Hits (filled circles; adolescents <italic>n</italic> = 36, adults <italic>n</italic> = 41) and misses (empty circles; adolescents <italic>n</italic> = 6, adults <italic>n</italic> = 15). <bold>(B)</bold> Adolescents displayed an increase in CS-elicited freezing across fear conditioning. <bold>(C)</bold> Acutely manipulating IL D1R or D2R signaling had no effect on adolescent extinction within-session, with all rats showing initial high levels of CS-elicited freezing that decreased as the extinction proceeded. <bold>(D)</bold> Adolescents that received in intra-IL vehicle or SKF-81297 at the time of extinction returned to high levels of CS-elicited freezing when tested the next day, while adolescents that received intra-IL quinpirole did not. <bold>(E)</bold> Adults displayed an increase in CS-elicited freezing across fear conditioning. <bold>(F)</bold> Acutely manipulating adult IL D2R signaling transiently impaired within-session extinction, however all adult rats inhibited CS-elicited freezing to a comparable level by the end of extinction training, irrespective of intracranial drug treatment. <bold>(G)</bold> Enhancing IL D1R or D2R signaling at the time of extinction training had no effect on long-term extinction in adults. Data represent mean &#x000B1; SEM. *<italic>p</italic> &#x0003C; 0.05.</p></caption>
<graphic xlink:href="fnbeh-11-00032-g0003.tif"/>
</fig>
<p>Adolescents displayed a significant increase in CS-elicited freezing across conditioning (Figure <xref ref-type="fig" rid="F3">3B</xref>; <italic>F</italic><sub>(2,70)</sub> = 13.5, <italic>p</italic> &#x0003C; 0.05). The next day, all adolescents showed comparable extinction with no differences between drug groups (Figure <xref ref-type="fig" rid="F3">3C</xref>). RM ANOVA showed an effect of extinction block (<italic>F</italic><sub>(5,165)</sub> = 16.9, <italic>p</italic> &#x0003C; 0.05), with no effect of drug and no interaction (<italic>F</italic>s &#x0003C; 1). Interestingly, quinpirole prevented the return of extinguished fear at test (Figure <xref ref-type="fig" rid="F3">3D</xref>). RM ANOVA of the final block of extinction compared to test revealed an effect of day (<italic>F</italic><sub>(1,33)</sub> = 6.3, <italic>p</italic> &#x0003C; 0.05) and an interaction between day and drug (<italic>F</italic><sub>(2,33)</sub> = 3.5, <italic>p</italic> &#x0003C; 0.05), and no effect of drug (<italic>F</italic> &#x0003C; 1). <italic>Post hoc</italic> tests found a significant difference in freezing levels at extinction vs. test for vehicle (<italic>t</italic><sub>(18)</sub> = 3.6, <italic>p</italic> &#x0003C; 0.05) and SKF-81297 (<italic>t</italic><sub>(7)</sub> = 2.6, <italic>p</italic> &#x0003C; 0.05), but not for quinpirole (<italic>t</italic> &#x0003C; 1). Thus, acutely enhancing IL D2R signaling at the time of extinction improved long-term extinction in adolescents.</p>
<p>Adults also displayed a significant increase in CS-elicited freezing during conditioning (Figure <xref ref-type="fig" rid="F3">3E</xref>; <italic>F</italic><sub>(2,80)</sub> = 75.1, <italic>p</italic> &#x0003C; 0.05). The next day, acutely manipulating IL D1R or D2R signaling in adults had a transient effect on within-session extinction, however all adults inhibited freezing to a comparable level by the end of extinction training (Figure <xref ref-type="fig" rid="F3">3F</xref>). RM ANOVA showed an effect of extinction block (<italic>F</italic><sub>(5,190)</sub> = 24.9, <italic>p</italic> &#x0003C; 0.05) and a block &#x000D7; drug interaction (<italic>F</italic><sub>(10,190)</sub> = 2.0, <italic>p</italic> &#x0003C; 0.05), but no overall effect of drug (<italic>F</italic><sub>(2,38)</sub> = 1.6, <italic>p</italic> = 0.2). When the interaction was examined with one-way ANOVA of individual extinction blocks (with Tukey HSD multiple comparisons), an effect of drug at extinction block 5 only was revealed (<italic>F</italic><sub>(2,38)</sub> = 3.3, <italic>p</italic> &#x0003C; 0.05), with quinpirole group freezing higher than the other two groups (<italic>p</italic>s &#x0003C; 0.05). This result indicates that quinpirole delayed within-session extinction for adults. RM ANOVA of extinction vs. test showed an effect of day (<italic>F</italic><sub>(1,38)</sub> = 13.0, <italic>p</italic> &#x0003C; 0.05), with no effect of drug (<italic>F</italic><sub>(2,38)</sub> = 1.0, <italic>p</italic> = 0.4), and no interaction (<italic>F</italic><sub>(2,38)</sub> = 1.4, <italic>p</italic> = 0.2). Thus increasing IL D1R or D2R signaling at the time of extinction had no effect on long-term extinction in adults (Figure <xref ref-type="fig" rid="F3">3G</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Here we show that adolescent rats display a deficit in long-term extinction of a conditioned fear response compared to adult rats. We also showed that D1R/D2R ratio is decreased following extinction in adolescents and increased in adults. Further, enhancing IL D2R signaling using quinpirole improved long-term extinction in adolescent rats but delayed extinction acquisition in adult rats, while increasing IL D1R signaling using SKF-81297 had no effects at any age. Present findings further highlight that adolescent extinction impairments relate to developmental changes in mPFC function, and identify for the first time that maturation of PFC dopamine signaling plays a role.</p>
<p>Our behavioral findings are consistent with previous studies that report impaired fear extinction in adolescents compared to adults in both rodents and humans (McCallum et al., <xref ref-type="bibr" rid="B52">2010</xref>; Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>; Pattwell et al., <xref ref-type="bibr" rid="B62">2012</xref>; Baker and Richardson, <xref ref-type="bibr" rid="B9">2015</xref>). These data add to a growing literature suggesting that adolescence is characterized by impairments in cue extinction more broadly, since adolescent rats also display deficits in extinction of a cocaine-associated context (Brenhouse and Andersen, <xref ref-type="bibr" rid="B14">2008</xref>) and a cocaine-associated cue (Zbukvic et al., <xref ref-type="bibr" rid="B88">2016</xref>). Importantly, the present findings recapitulate clinical evidence that extinction-based therapy for anxiety disorders is less effective in adolescents compared to other ages (Southam-Gerow et al., <xref ref-type="bibr" rid="B78">2001</xref>; Bodden et al., <xref ref-type="bibr" rid="B11">2008</xref>).</p>
<p>Prior to extinction, adolescents displayed increased D1R and D1R/D2R ratio mRNA compared to adults. This is consistent with studies that report a peak in D1R gene expression (Rothmond et al., <xref ref-type="bibr" rid="B72">2012</xref>; Garske et al., <xref ref-type="bibr" rid="B24">2013</xref>) and receptor expression (Andersen et al., <xref ref-type="bibr" rid="B6">2000</xref>; Brenhouse et al., <xref ref-type="bibr" rid="B15">2008</xref>) in the PFC during adolescence. In particular, previous findings indicate that early life adversity can exacerbate an adolescent peak in D1R expression on PFC projection neurons in rats (Brenhouse et al., <xref ref-type="bibr" rid="B13">2013</xref>). Therefore, the increased adolescent D1R/D2R ratio observed in the present study may be a result of fear conditioning. By comparison, we found no age difference in D2R gene expression, in line with reports that D2R expression in the mPFC reaches stable adult levels by adolescence (Tarazi et al., <xref ref-type="bibr" rid="B81">1998</xref>).</p>
<p>Since patterns of basal D1R and D2R mRNA expression in the cortex are found to correlate with receptor binding (Weiner et al., <xref ref-type="bibr" rid="B87">1991</xref>), the current findings imply a markedly different prefrontal dopaminergic environment pre-extinction depending on age, with adolescent mPFC networks likely dominated by D1R activity relative to D2R activity compared to adults. Computational modeling predicts that when the PFC is dominated by D1R relative to D2R signaling, this produces a state of net inhibition (Seamans and Yang, <xref ref-type="bibr" rid="B74">2004</xref>). Notably, the present findings in adolescents are similar to reports of rats with lesions of the mPFC, where fear conditioning and within-session extinction learning are intact but long-term extinction is impaired (Quirk et al., <xref ref-type="bibr" rid="B70">2000</xref>; Garcia et al., <xref ref-type="bibr" rid="B23">2006</xref>). Moreover, it appears that the mPFC is not recruited as efficiently during fear extinction in adolescence compared to adulthood (Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>; Pattwell et al., <xref ref-type="bibr" rid="B62">2012</xref>; Baker and Richardson, <xref ref-type="bibr" rid="B9">2015</xref>). In humans, the intense emotionality of adolescents is thought be at least partly due to an under-recruitment of the PFC (Somerville et al., <xref ref-type="bibr" rid="B77">2010</xref>). The present findings suggest that the mPFC dopaminergic profile may contribute to adolescent emotionality.</p>
<p>Since we observed age differences in prefrontal dopamine receptor gene expression following extinction learning, we then sought to examine functional differences in dopamine signaling across adolescence vs. adulthood. Therefore, we investigated the immediate and long-term effect of enhancing D1R or D2R signaling in the IL of the PFC at the time of extinction learning. This subregion of the PFC is homologous to Brodmann Area 25 in the human brain (Gass and Chandler, <xref ref-type="bibr" rid="B25">2013</xref>). Critically, both the IL of rodents and the corresponding ventromedial PFC in humans have been strongly implicated in extinction learning and retrieval, whereas the prelimbic subregion (PrL) is involved in fear expression (Quirk et al., <xref ref-type="bibr" rid="B70">2000</xref>; Phelps et al., <xref ref-type="bibr" rid="B66">2004</xref>; Sierra-Mercado et al., <xref ref-type="bibr" rid="B76">2011</xref>). Changes in dopamine receptor gene expression following extinction, and the opposite effects observed in adolescent vs. adult rats following the manipulation of prefrontal D2R activity suggest a fundamental dissociation in dopaminergic signaling in the mPFC in relation to extinction across adolescence. Adolescent data are consistent with previous findings that intra-IL quinpirole improves extinction of a discrete cocaine-associated cue in adolescent rats (Zbukvic et al., <xref ref-type="bibr" rid="B88">2016</xref>), suggesting a role for prefrontal D2R signaling across extinction learning broadly. In contrast, intra-IL quinpirole delayed the acquisition of extinction in adult rats, with no effect on long-term extinction. This is consistent with previous reports of systemic quinpirole delaying extinction in adult rats (Nader and LeDoux, <xref ref-type="bibr" rid="B58">1999</xref>; Ponnusamy et al., <xref ref-type="bibr" rid="B68">2005</xref>). However, systemic or ICV treatment with the D2R antagonist haloperidol (Holtzman-Assif et al., <xref ref-type="bibr" rid="B31">2010</xref>), or intra-IL or systemic treatment with the D2R antagonist raclopride (Mueller et al., <xref ref-type="bibr" rid="B56">2010</xref>) at the time of extinction have been shown to impair the retrieval of extinction the next day in adult rats. Disparities between findings may be due to the specificity of agonists and antagonists used, and/or route of administration (Gehlert et al., <xref ref-type="bibr" rid="B26">1992</xref>; Bowery et al., <xref ref-type="bibr" rid="B12">1994</xref>; Tseng and O&#x02019;Donnell, <xref ref-type="bibr" rid="B83">2007</xref>). Present findings suggest that the level of D2R signaling in the adult IL may be naturally optimal compared to adolescents for extinction learning, and further activation by quinpirole might disrupt this balance. Overall, divergent effects of intra-IL quinpirole add to gene expression data suggesting that that the IL of the PFC is involved in extinction learning during adolescence as well as adulthood, however that extinction may involve differential D2R signaling across development. In contrast, we found the D1R agonist SKF-81297 had no effects on within-session or long-term extinction in either adolescent or adult rats. Previous studies using adult rodents report that attenuating IL D1R signaling impairs extinction (Hikind and Maroun, <xref ref-type="bibr" rid="B29">2008</xref>; Fricks-Gleason et al., <xref ref-type="bibr" rid="B20">2012</xref>). By comparison, systemic treatment with a D1R agonist enhanced extinction of cued and contextual fear in adult rats, though the anatomical targets of that effect were not clear (Abraham et al., <xref ref-type="bibr" rid="B2">2016</xref>). It may be that enhancing IL D1R activity is not sufficient for extinction in adolescence and adulthood.</p>
<p>We note that in the final experiment of the present study, we observed a small spontaneous recovery of extinguished freezing 24 h following extinction in adult rats that received saline infusion into the IL before extinction. This was not observed in our first experiment, as well as in our and other groups&#x02019; previous studies (Quirk, <xref ref-type="bibr" rid="B69">2002</xref>; McCallum et al., <xref ref-type="bibr" rid="B52">2010</xref>; Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>; Orsini et al., <xref ref-type="bibr" rid="B60">2011</xref>). A careful examination of the literature revealed that pre-extinction infusion of saline or vehicle into the IL or the PrL, but not other brain regions, may cause this effect in adult rats (Sierra-Mercado et al., <xref ref-type="bibr" rid="B76">2011</xref>). This small but significant spontaneous recovery due to pre-extinction vehicle infusion appears to also be present even when the freezing was well extinguished to baseline (i.e., &#x0007E;0%), and when vehicle has also been infused during test to provide identical physiological contexts for extinction and test (Laurent and Westbrook, <xref ref-type="bibr" rid="B45">2008</xref>). In studies that do not involves such saline or vehicle infusions into the IL, adult rodents maintain low levels of freezing following extinction (Quirk, <xref ref-type="bibr" rid="B69">2002</xref>; McCallum et al., <xref ref-type="bibr" rid="B52">2010</xref>; Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>; Orsini et al., <xref ref-type="bibr" rid="B60">2011</xref>). Therefore, we believe that the result of our final experiment does not affect the interpretation of our data. Additionally, there was a significant effect of age during conditioning for qPCR experiment, whereas there was only a trend in the behavioral experiment. Based on the results of microinfusion experiments, we believe that adolescent rats showed reduced freezing during conditioning compared to adults in the present study. While these results are inconsistent with previous findings (McCallum et al., <xref ref-type="bibr" rid="B52">2010</xref>; Kim et al., <xref ref-type="bibr" rid="B42">2011</xref>), there are more recent studies that do not report conditioning data in extinction across adolescence (Pattwell et al., <xref ref-type="bibr" rid="B62">2012</xref>, <xref ref-type="bibr" rid="B63">2016</xref>). Importantly, freezing levels during extinction were comparable in adolescent and adults in all experiments of the present study.</p>
<p>Further studies are required to confirm age differences in D1R vs. D2R protein expression following fear conditioning and extinction, although antibodies that are specific to D1R or D2R, and not any other dopamine receptor subtypes are notoriously lacking. Specifically, D1R and D2R proteins show striking structural similarities, which have implications for visualization and quantification in brain tissue. For instance, sequence similarity searching using the Basic Local Alignment Search Tool (BLAST) database reveals that D1R and D2R share 77% of their amino acid sequence (Agostino, <xref ref-type="bibr" rid="B3">2012</xref>). It follows that D1R and D2R display similar ligand binding profiles (Levey et al., <xref ref-type="bibr" rid="B49">1993</xref>). This means that commercially available antibodies for D1R and D2R are liable to display cross-reactivity (Michel et al., <xref ref-type="bibr" rid="B54">2009</xref>; Hutchings et al., <xref ref-type="bibr" rid="B32">2010</xref>). Immunostaining of D2R in particular has historically shown conflicting results across previous literature, with some studies reporting extensive labeling throughout all layers of cortex (Ariano et al., <xref ref-type="bibr" rid="B8">1993</xref>), while others have shown little to no staining (Levey et al., <xref ref-type="bibr" rid="B49">1993</xref>; Sesack et al., <xref ref-type="bibr" rid="B75">1994</xref>). Therefore, present qPCR findings offer an exciting first step to elucidating how the maturing prefrontal dopamine system may contribute to extinction across adolescence.</p>
<p>Epidemiological data indicate that persistence of mental health problems among adolescents relates more to recurrence rather than chronicity of youth-onset disorders (Kessler et al., <xref ref-type="bibr" rid="B37">2012</xref>). Our data suggest that this may be due, at least in part, to extinction impairments at this age. Not only do we demonstrate that adolescent rats are impaired in long-term extinction, we also show for the first time that extinction produces unique changes dopamine receptor gene expression across development. Importantly, present findings highlight D2R as a promising pharmacological target to improve exposure therapy in adolescents, which is consistent with our recent observation that the partial agonist of the D2R, aripiprazole, can significantly facilitate long-term extinction in adolescent rats (Ganella et al. under review). While behavioral therapies that involve exposure therapy are the most effective way to treat anxiety disorders, less than one in five adolescents have received therapy for their anxiety (Merikangas et al., <xref ref-type="bibr" rid="B53">2011</xref>). We propose that an effective pharmacological adjunct that acutely accompanies behavioral therapy could significantly reduce the amount of treatment necessary during this vulnerable period, and reduce chronic use of medication. Given that neural correlates of adolescent behavior are highly conserved across species (Spear, <xref ref-type="bibr" rid="B79">2000</xref>), present findings represent an important step to developing more effective treatments for adolescents living with anxiety disorders.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>JHK and ICZ conceptualized and designed the study. ICZ, CHJP and DEG acquired the data. ICZ and JHK analyzed the data. ICZ, AJL and JHK interpreted the data. All authors were involved in critically revising the work for important intellectual content and in final approval of the version to be published. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>This work was supported by an Australian Postgraduate Award awarded to ICZ, Baker Foundation Fellowship awarded to DEG, a Principal Research Fellowship (APP1020737) from the National Health and Medical Research Council (NHMRC) of Australia awarded to AJL, NHMRC Career Development Fellowship (grant number APP1083309) awarded to JHK and NHMRC Project grant (APP1063140) awarded to JHK and AJL. Australian Research Council Discovery Grant (DP150102496) awarded to JHK.</p>
</sec>
<sec id="s7">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>We acknowledge the Victorian Government&#x02019;s Operational Infrastructure Support Program. We would also like to thank the Florey Behavior Core Facility.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname> <given-names>A. D.</given-names></name> <name><surname>Neve</surname> <given-names>K. A.</given-names></name> <name><surname>Lattal</surname> <given-names>K. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Dopamine and extinction: a convergence of theory with fear and reward circuitry</article-title>. <source>Neurobiol. Learn. Mem.</source> <volume>108</volume>, <fpage>65</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2013.11.007</pub-id><pub-id pub-id-type="pmid">24269353</pub-id></citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname> <given-names>A. D.</given-names></name> <name><surname>Neve</surname> <given-names>K. A.</given-names></name> <name><surname>Lattal</surname> <given-names>K. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Activation of D1/5 dopamine receptors: a common mechanism for enhancing extinction of fear and reward-seeking behaviors</article-title>. <source>Neuropsychopharmacology</source> <volume>41</volume>, <fpage>2072</fpage>&#x02013;<lpage>2081</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2016.5</pub-id><pub-id pub-id-type="pmid">26763483</pub-id></citation></ref>
<ref id="B3"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Agostino</surname> <given-names>M.</given-names></name></person-group> (<year>2012</year>). <source>Practical Bioinformatics.</source> <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Garland Science</publisher-name>.</citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname> <given-names>P. H.</given-names></name> <name><surname>Gingrich</surname> <given-names>J. A.</given-names></name> <name><surname>Bates</surname> <given-names>M. D.</given-names></name> <name><surname>Dearry</surname> <given-names>A.</given-names></name> <name><surname>Falardeau</surname> <given-names>P.</given-names></name> <name><surname>Senogles</surname> <given-names>S. E.</given-names></name> <etal/></person-group>. (<year>1990</year>). <article-title>Dopamine receptor subtypes: beyond the D1/D2 classification</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>11</volume>, <fpage>231</fpage>&#x02013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/0165-6147(90)90249-8</pub-id><pub-id pub-id-type="pmid">2200181</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname> <given-names>S. L.</given-names></name> <name><surname>Dumont</surname> <given-names>N. L.</given-names></name> <name><surname>Teicher</surname> <given-names>M. H.</given-names></name></person-group> (<year>1997</year>). <article-title>Developmental differences in dopamine synthesis inhibition by (&#x000B1;)-7-OH-DPAT</article-title>. <source>Naunyn Schmiedebergs Arch. Pharmacol.</source> <volume>356</volume>, <fpage>173</fpage>&#x02013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1007/pl00005038</pub-id><pub-id pub-id-type="pmid">9272722</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname> <given-names>S. L.</given-names></name> <name><surname>Thompson</surname> <given-names>A. T.</given-names></name> <name><surname>Rutstein</surname> <given-names>M.</given-names></name> <name><surname>Hostetter</surname> <given-names>J. C.</given-names></name> <name><surname>Teicher</surname> <given-names>M. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats</article-title>. <source>Synapse</source> <volume>37</volume>, <fpage>167</fpage>&#x02013;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1002/1098-2396(200008)37:2&#x0003C;167::AID-SYN11&#x0003E;3.0.CO;2-B</pub-id><pub-id pub-id-type="pmid">10881038</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Araki</surname> <given-names>K. Y.</given-names></name> <name><surname>Sims</surname> <given-names>J. R.</given-names></name> <name><surname>Bhide</surname> <given-names>P. G.</given-names></name></person-group> (<year>2007</year>). <article-title>Dopamine receptor mRNA and protein expression in the mouse corpus striatum and cerebral cortex during pre- and postnatal development</article-title>. <source>Brain Res.</source> <volume>1156</volume>, <fpage>31</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2007.04.043</pub-id><pub-id pub-id-type="pmid">17509542</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ariano</surname> <given-names>M. A.</given-names></name> <name><surname>Fisher</surname> <given-names>R. S.</given-names></name> <name><surname>Smyk-Randall</surname> <given-names>E.</given-names></name> <name><surname>Sibley</surname> <given-names>D. R.</given-names></name> <name><surname>Levine</surname> <given-names>M. S.</given-names></name></person-group> (<year>1993</year>). <article-title>D2 dopamine receptor distribution in the rodent CNS using anti-peptide antisera</article-title>. <source>Brain Res.</source> <volume>609</volume>, <fpage>71</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(93)90857-j</pub-id><pub-id pub-id-type="pmid">8508323</pub-id></citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>K. D.</given-names></name> <name><surname>Richardson</surname> <given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Forming competing fear learning and extinction memories in adolescence makes fear difficult to inhibit</article-title>. <source>Learn. Mem.</source> <volume>22</volume>, <fpage>537</fpage>&#x02013;<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1101/lm.039487.114</pub-id><pub-id pub-id-type="pmid">26472643</pub-id></citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beaulieu</surname> <given-names>J.-M.</given-names></name> <name><surname>Gainetdinov</surname> <given-names>R. R.</given-names></name></person-group> (<year>2011</year>). <article-title>The physiology, signaling, and pharmacology of dopamine receptors</article-title>. <source>Pharmacol. Rev.</source> <volume>63</volume>, <fpage>182</fpage>&#x02013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1124/pr.110.002642</pub-id><pub-id pub-id-type="pmid">21303898</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bodden</surname> <given-names>D. H. M.</given-names></name> <name><surname>B&#x000F6;gels</surname> <given-names>S. M.</given-names></name> <name><surname>Nauta</surname> <given-names>M. H.</given-names></name> <name><surname>De Haan</surname> <given-names>E.</given-names></name> <name><surname>Ringrose</surname> <given-names>J.</given-names></name> <name><surname>Appelboom</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2008</year>). <article-title>Child versus family cognitive-behavioral therapy in clinically anxious youth: an efficacy and partial effectiveness study</article-title>. <source>J. Am. Acad. Child. Adolesc. Psychiatry</source> <volume>47</volume>, <fpage>1384</fpage>&#x02013;<lpage>1394</lpage>. <pub-id pub-id-type="doi">10.1097/CHI.0b013e318189148e</pub-id><pub-id pub-id-type="pmid">18981932</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowery</surname> <given-names>B.</given-names></name> <name><surname>Rothwell</surname> <given-names>L. A.</given-names></name> <name><surname>Seabrook</surname> <given-names>G. R.</given-names></name></person-group> (<year>1994</year>). <article-title>Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area</article-title>. <source>Br. J. Pharmacol.</source> <volume>112</volume>, <fpage>873</fpage>&#x02013;<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1994.tb13161.x</pub-id><pub-id pub-id-type="pmid">7921615</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenhouse</surname> <given-names>H. C.</given-names></name> <name><surname>Andersen</surname> <given-names>S. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Delayed extinction and stronger reinstatement of cocaine conditioned place preference in adolescent rats, compared to adults</article-title>. <source>Behav. Neurosci.</source> <volume>122</volume>, <fpage>460</fpage>&#x02013;<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1037/0735-7044.122.2.460</pub-id><pub-id pub-id-type="pmid">18410184</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenhouse</surname> <given-names>H.</given-names></name> <name><surname>Lukkes</surname> <given-names>J.</given-names></name> <name><surname>Andersen</surname> <given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Early life adversity alters the developmental profiles of addiction-related prefrontal cortex circuitry</article-title>. <source>Brain Sci.</source> <volume>3</volume>, <fpage>143</fpage>&#x02013;<lpage>158</lpage>. <pub-id pub-id-type="doi">10.3390/brainsci3010143</pub-id><pub-id pub-id-type="pmid">24961311</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brenhouse</surname> <given-names>H. C.</given-names></name> <name><surname>Sonntag</surname> <given-names>K. C.</given-names></name> <name><surname>Andersen</surname> <given-names>S. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Transient D1 dopamine receptor expression on prefrontal cortex projection neurons: relationship to enhanced motivational salience of drug cues in adolescence</article-title>. <source>J. Neurosci.</source> <volume>28</volume>, <fpage>2375</fpage>&#x02013;<lpage>2382</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5064-07.2008</pub-id><pub-id pub-id-type="pmid">18322084</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>N. A.</given-names></name> <name><surname>Ganella</surname> <given-names>D. E.</given-names></name> <name><surname>Bathgate</surname> <given-names>R.</given-names></name> <name><surname>Chen</surname> <given-names>A.</given-names></name> <name><surname>Lawrence</surname> <given-names>A. J.</given-names></name> <name><surname>Kim</surname> <given-names>J. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Knockdown of corticotropin-releasing factor 1 receptors in the ventral tegmental area enhances conditioned fear</article-title>. <source>Eur. Neuropsychopharmacol.</source> <volume>26</volume>, <fpage>1533</fpage>&#x02013;<lpage>1540</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2016.06.002</pub-id><pub-id pub-id-type="pmid">27397862</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>El-Ghundi</surname> <given-names>M.</given-names></name> <name><surname>O&#x02019;Dowd</surname> <given-names>B. F.</given-names></name> <name><surname>George</surname> <given-names>S. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Prolonged fear responses in mice lacking dopamine D1 receptor</article-title>. <source>Brain Res.</source> <volume>892</volume>, <fpage>86</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-8993(00)03234-0</pub-id><pub-id pub-id-type="pmid">11172752</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floresco</surname> <given-names>S. B.</given-names></name> <name><surname>Phillips</surname> <given-names>A. G.</given-names></name></person-group> (<year>2001</year>). <article-title>Delay-dependent modulation of memory retrieval by infusion of a dopamine D-sub-1 agonist into the rat medial prefrontal cortex</article-title>. <source>Behav. Neurosci.</source> <volume>115</volume>, <fpage>934</fpage>&#x02013;<lpage>939</lpage>. <pub-id pub-id-type="doi">10.1037//0735-7044.115.4.934</pub-id><pub-id pub-id-type="pmid">11508732</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floresco</surname> <given-names>S. B.</given-names></name> <name><surname>Magyar</surname> <given-names>O.</given-names></name> <name><surname>Ghods-Sharifi</surname> <given-names>S.</given-names></name> <name><surname>Vexelman</surname> <given-names>C.</given-names></name> <name><surname>Tse</surname> <given-names>M. T. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting</article-title>. <source>Neuropsychopharmacology</source> <volume>31</volume>, <fpage>297</fpage>&#x02013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1300825</pub-id><pub-id pub-id-type="pmid">16012531</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fricks-Gleason</surname> <given-names>A. N.</given-names></name> <name><surname>Khalaj</surname> <given-names>A. J.</given-names></name> <name><surname>Marshall</surname> <given-names>J. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Dopamine D1 receptor antagonism impairs extinction of cocaine-cue memories</article-title>. <source>Behav. Brain Res.</source> <volume>226</volume>, <fpage>357</fpage>&#x02013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2011.08.019</pub-id><pub-id pub-id-type="pmid">21871500</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ganella</surname> <given-names>D. E.</given-names></name> <name><surname>Thangaraju</surname> <given-names>P.</given-names></name> <name><surname>Lawrence</surname> <given-names>A. J.</given-names></name> <name><surname>Kim</surname> <given-names>J. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Fear extinction in 17 day old rats is dependent on metabotropic glutamate receptor 5 signaling</article-title>. <source>Behav. Brain Res.</source> <volume>298</volume>, <fpage>32</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.12.010</pub-id><pub-id pub-id-type="pmid">25497704</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia</surname> <given-names>R.</given-names></name> <name><surname>Chang</surname> <given-names>C.-H.</given-names></name> <name><surname>Maren</surname> <given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Electrolytic lesions of the medial prefrontal cortex do not interfere with long-term memory of extinction of conditioned fear</article-title>. <source>Learn. Mem.</source> <volume>13</volume>, <fpage>14</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1101/lm.60406</pub-id><pub-id pub-id-type="pmid">16418435</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garske</surname> <given-names>A. K.</given-names></name> <name><surname>Lawyer</surname> <given-names>C. R.</given-names></name> <name><surname>Peterson</surname> <given-names>B. M.</given-names></name> <name><surname>Illig</surname> <given-names>K. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Adolescent changes in dopamine D1 receptor expression in orbitofrontal cortex and piriform cortex accompany an associative learning deficit</article-title>. <source>PLoS One</source> <volume>8</volume>:<fpage>e56191</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0056191</pub-id><pub-id pub-id-type="pmid">23437091</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gass</surname> <given-names>J. T.</given-names></name> <name><surname>Chandler</surname> <given-names>L. J.</given-names></name></person-group> (<year>2013</year>). <article-title>The plasticity of extinction: contribution of the prefrontal cortex in treating addiction through inhibitory learning</article-title>. <source>Front. Psychiatry</source> <volume>4</volume>:<fpage>46</fpage>. <pub-id pub-id-type="doi">10.3389/fpsyt.2013.00046</pub-id><pub-id pub-id-type="pmid">23750137</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gehlert</surname> <given-names>D. R.</given-names></name> <name><surname>Gackenheimer</surname> <given-names>S. L.</given-names></name> <name><surname>Seeman</surname> <given-names>P.</given-names></name> <name><surname>Schaus</surname> <given-names>J.</given-names></name></person-group> (<year>1992</year>). <article-title>Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain</article-title>. <source>Eur. J. Pharmacol.</source> <volume>211</volume>, <fpage>189</fpage>&#x02013;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(92)90528-c</pub-id><pub-id pub-id-type="pmid">1351846</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>L. W.</given-names></name> <name><surname>Lockstone</surname> <given-names>H. E.</given-names></name> <name><surname>Khaitovich</surname> <given-names>P.</given-names></name> <name><surname>Weickert</surname> <given-names>C. S.</given-names></name> <name><surname>Webster</surname> <given-names>M. J.</given-names></name> <name><surname>Bahn</surname> <given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Gene expression in the prefrontal cortex during adolescence: implications for the onset of schizophrenia</article-title>. <source>BMC Med. Genomics</source> <volume>2</volume>:<fpage>28</fpage>. <pub-id pub-id-type="doi">10.1186/1755-8794-2-28</pub-id><pub-id pub-id-type="pmid">19457239</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartley</surname> <given-names>C. A.</given-names></name> <name><surname>Casey</surname> <given-names>B. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Risk for anxiety and implications for treatment: developmental, environmental, and genetic factors governing fear regulation</article-title>. <source>Ann. N Y Acad. Sci.</source> <volume>1304</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1111/nyas.12287</pub-id><pub-id pub-id-type="pmid">24147742</pub-id></citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hikind</surname> <given-names>N.</given-names></name> <name><surname>Maroun</surname> <given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Microinfusion of the D1 receptor antagonist, SCH23390 into the IL but not the BLA impairs consolidation of extinction of auditory fear conditioning</article-title>. <source>Neurobiol. Learn. Mem.</source> <volume>90</volume>, <fpage>217</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2008.03.003</pub-id><pub-id pub-id-type="pmid">18442937</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmes</surname> <given-names>A.</given-names></name> <name><surname>Quirk</surname> <given-names>G. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders&#x02014;the case of yohimbine</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>31</volume>, <fpage>2</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2009.10.003</pub-id><pub-id pub-id-type="pmid">20036429</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holtzman-Assif</surname> <given-names>O.</given-names></name> <name><surname>Laurent</surname> <given-names>V.</given-names></name> <name><surname>Westbrook</surname> <given-names>R. F.</given-names></name></person-group> (<year>2010</year>). <article-title>Blockade of dopamine activity in the nucleus accumbens impairs learning extinction of conditioned fear</article-title>. <source>Learn. Mem.</source> <volume>17</volume>, <fpage>71</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1101/lm.1668310</pub-id><pub-id pub-id-type="pmid">20154351</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hutchings</surname> <given-names>C. J.</given-names></name> <name><surname>Koglin</surname> <given-names>M.</given-names></name> <name><surname>Marshall</surname> <given-names>F. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Therapeutic antibodies directed at G protein-coupled receptors</article-title>. <source>MAbs</source> <volume>2</volume>, <fpage>594</fpage>&#x02013;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.4161/mabs.2.6.13420</pub-id><pub-id pub-id-type="pmid">20864805</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jaber</surname> <given-names>M.</given-names></name> <name><surname>Robinson</surname> <given-names>S. W.</given-names></name> <name><surname>Missales</surname> <given-names>C.</given-names></name> <name><surname>Caron</surname> <given-names>M. G.</given-names></name></person-group> (<year>1996</year>). <article-title>Dopamine receptors and brain function</article-title>. <source>Neuropharmacology</source> <volume>35</volume>, <fpage>1503</fpage>&#x02013;<lpage>1519</lpage>. <pub-id pub-id-type="doi">10.1016/s0028-3908(96)00100-1</pub-id><pub-id pub-id-type="pmid">9025098</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname> <given-names>D. M.</given-names></name> <name><surname>Westlind-Danielsson</surname> <given-names>A.</given-names></name></person-group> (<year>1994</year>). <article-title>Dopamine receptors: molecular biology, biochemistry and behavioural aspects</article-title>. <source>Pharmacol. Ther.</source> <volume>64</volume>, <fpage>291</fpage>&#x02013;<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1016/0163-7258(94)90041-8</pub-id><pub-id pub-id-type="pmid">7878079</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jucaite</surname> <given-names>A.</given-names></name> <name><surname>Forssberg</surname> <given-names>H.</given-names></name> <name><surname>Karlsson</surname> <given-names>P.</given-names></name> <name><surname>Halldin</surname> <given-names>C.</given-names></name> <name><surname>Farde</surname> <given-names>L.</given-names></name></person-group> (<year>2010</year>). <article-title>Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study</article-title>. <source>Neuroscience</source> <volume>167</volume>, <fpage>104</fpage>&#x02013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2010.01.034</pub-id><pub-id pub-id-type="pmid">20109534</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalsbeek</surname> <given-names>A.</given-names></name> <name><surname>Voorn</surname> <given-names>P.</given-names></name> <name><surname>Buijs</surname> <given-names>R. M.</given-names></name> <name><surname>Pool</surname> <given-names>C. W.</given-names></name> <name><surname>Uylings</surname> <given-names>H.</given-names></name></person-group> (<year>1988</year>). <article-title>Development of the dopaminergic innervation in the prefrontal cortex of the rat</article-title>. <source>J. Comp. Neurol.</source> <volume>269</volume>, <fpage>58</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1002/cne.902690105</pub-id><pub-id pub-id-type="pmid">3361004</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname> <given-names>R. C.</given-names></name> <name><surname>Avenevoli</surname> <given-names>S.</given-names></name> <name><surname>Costello</surname> <given-names>E. J.</given-names></name> <name><surname>Georgiades</surname> <given-names>K.</given-names></name> <name><surname>Green</surname> <given-names>J. G.</given-names></name> <name><surname>Gruber</surname> <given-names>M. J.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Prevalence, persistence and sociodemographic correlates of DSM-IV disorders in the National comorbidity survey replication adolescent supplement</article-title>. <source>Arch. Gen. Psychiatry</source> <volume>69</volume>, <fpage>372</fpage>&#x02013;<lpage>380</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2011.160</pub-id><pub-id pub-id-type="pmid">22147808</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Ganella</surname> <given-names>D. E.</given-names></name></person-group> (<year>2015</year>). <article-title>A review of preclinical studies to understand fear during adolescence</article-title>. <source>Aust. Psychol.</source> <volume>50</volume>, <fpage>25</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1111/ap.12066</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Hamlin</surname> <given-names>A. S.</given-names></name> <name><surname>Richardson</surname> <given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Fear extinction across development: the involvement of the medial prefrontal cortex as assessed by temporary inactivation and immunohistochemistry</article-title>. <source>J. Neurosci.</source> <volume>29</volume>, <fpage>10802</fpage>&#x02013;<lpage>10808</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0596-09.2009</pub-id><pub-id pub-id-type="pmid">19726637</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Lawrence</surname> <given-names>A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Drugs currently in phase II trials for cocaine addiction</article-title>. <source>Expert Opin. Investig. Drugs</source> <volume>23</volume>, <fpage>1105</fpage>&#x02013;<lpage>1122</lpage>. <pub-id pub-id-type="doi">10.1517/13543784.2014.915312</pub-id><pub-id pub-id-type="pmid">24773297</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Richardson</surname> <given-names>R.</given-names></name></person-group> (<year>2011</year>). <article-title>Immunohistochemical analyses of long-term extinction of conditioned fear in adolescent rats</article-title>. <source>Cereb. Cortex</source> <volume>21</volume>, <fpage>530</fpage>&#x02013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhq116</pub-id><pub-id pub-id-type="pmid">20576926</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Perry</surname> <given-names>C. J.</given-names></name> <name><surname>Ganella</surname> <given-names>D. E.</given-names></name> <name><surname>Madsen</surname> <given-names>H. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Postnatal development of neurotransmitter systems and their relevance in extinction of conditioned fear</article-title>. <source>Neurobiol. Learn. Mem.</source> [Epub ahead of print]. <pub-id pub-id-type="doi">10.1016/j.nlm.2016.10.018</pub-id><pub-id pub-id-type="pmid">27818267</pub-id></citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Richardson</surname> <given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Extinction in preweanling rats does not involve NMDA receptors</article-title>. <source>Neurobiol. Learn. Mem.</source> <volume>94</volume>, <fpage>176</fpage>&#x02013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/j.nlm.2010.05.004</pub-id><pub-id pub-id-type="pmid">20472087</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kirino</surname> <given-names>E.</given-names></name></person-group> (<year>2012</year>). <article-title>Efficacy and safety of aripiprazole in child and adolescent patients</article-title>. <source>Eur. Child Adolesc. Psychiatry</source> <volume>21</volume>, <fpage>361</fpage>&#x02013;<lpage>368</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-012-0270-0</pub-id><pub-id pub-id-type="pmid">22447196</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laurent</surname> <given-names>V.</given-names></name> <name><surname>Westbrook</surname> <given-names>R. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Distinct contributions of the basolateral amygdala and the medial prefrontal cortex to learning and relearning extinction of context conditioned fear</article-title>. <source>Learn. Mem.</source> <volume>15</volume>, <fpage>657</fpage>&#x02013;<lpage>666</lpage>. <pub-id pub-id-type="doi">10.1101/lm.1080108</pub-id><pub-id pub-id-type="pmid">18772253</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauzon</surname> <given-names>N. M.</given-names></name> <name><surname>Bishop</surname> <given-names>S. F.</given-names></name> <name><surname>Laviolette</surname> <given-names>S. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Dopamine D1 versus D4 receptors differentially modulate the encoding of salient versus nonsalient emotional information in the medial prefrontal cortex</article-title>. <source>J. Neurosci.</source> <volume>29</volume>, <fpage>4836</fpage>&#x02013;<lpage>4845</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0178-09.2009</pub-id><pub-id pub-id-type="pmid">19369552</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laviola</surname> <given-names>G.</given-names></name> <name><surname>Macr&#x000EC;</surname> <given-names>S.</given-names></name> <name><surname>Morley-Fletcher</surname> <given-names>S.</given-names></name> <name><surname>Adriani</surname> <given-names>W.</given-names></name></person-group> (<year>2003</year>). <article-title>Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>27</volume>, <fpage>19</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/s0149-7634(03)00006-x</pub-id><pub-id pub-id-type="pmid">12732220</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leslie</surname> <given-names>C. A.</given-names></name> <name><surname>Robertson</surname> <given-names>M. W.</given-names></name> <name><surname>Cutler</surname> <given-names>A. J.</given-names></name> <name><surname>Bennett</surname> <given-names>J. P.</given-names></name></person-group> (<year>1991</year>). <article-title>Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis</article-title>. <source>Dev. Brain Res.</source> <volume>62</volume>, <fpage>109</fpage>&#x02013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1016/0165-3806(91)90195-o</pub-id><pub-id pub-id-type="pmid">1836980</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levey</surname> <given-names>A. I.</given-names></name> <name><surname>Hersch</surname> <given-names>S. M.</given-names></name> <name><surname>Rye</surname> <given-names>D. B.</given-names></name> <name><surname>Sunahara</surname> <given-names>R. K.</given-names></name> <name><surname>Niznik</surname> <given-names>H. B.</given-names></name> <name><surname>Kitt</surname> <given-names>C. A.</given-names></name> <etal/></person-group>. (<year>1993</year>). <article-title>Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>90</volume>, <fpage>8861</fpage>&#x02013;<lpage>8865</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.90.19.8861</pub-id><pub-id pub-id-type="pmid">8415621</pub-id></citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>K. J.</given-names></name> <name><surname>Schmittgen</surname> <given-names>T. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2<sup>&#x02212;&#x00394;&#x00394;CT</sup> method</article-title>. <source>Methods</source> <volume>25</volume>, <fpage>402</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname> <given-names>H. M.</given-names></name> <name><surname>Kim</surname> <given-names>J. H.</given-names></name></person-group> (<year>2016</year>). <article-title>Ontogeny of memory: an update on 40 years of work on infantile amnesia</article-title>. <source>Behav. Brain Res.</source> <volume>298</volume>, <fpage>4</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2015.07.030</pub-id><pub-id pub-id-type="pmid">26190765</pub-id></citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McCallum</surname> <given-names>J.</given-names></name> <name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Richardson</surname> <given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Impaired extinction retention in adolescent rats: effects of D-cycloserine</article-title>. <source>Neuropsychopharmacology</source> <volume>35</volume>, <fpage>2134</fpage>&#x02013;<lpage>2142</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2010.92</pub-id><pub-id pub-id-type="pmid">20592716</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merikangas</surname> <given-names>K. R.</given-names></name> <name><surname>He</surname> <given-names>J.-P.</given-names></name> <name><surname>Burstein</surname> <given-names>M.</given-names></name> <name><surname>Swendsen</surname> <given-names>J.</given-names></name> <name><surname>Avenevoli</surname> <given-names>S.</given-names></name> <name><surname>Case</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Service utilization for lifetime mental disorders in U.S. adolescents: results of the National comorbidity survey-adolescent supplement (NCS-A)</article-title>. <source>J. Am. Acad. Child Adolesc. Psychiatry</source> <volume>50</volume>, <fpage>32</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2010.10.006</pub-id><pub-id pub-id-type="pmid">21156268</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname> <given-names>M. C.</given-names></name> <name><surname>Wieland</surname> <given-names>T.</given-names></name> <name><surname>Tsujimoto</surname> <given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>How reliable are G-protein-coupled receptor antibodies?</article-title> <source>Naunyn Schmiedebergs Arch. Pharmacol.</source> <volume>379</volume>, <fpage>385</fpage>&#x02013;<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1007/s00210-009-0395-y</pub-id><pub-id pub-id-type="pmid">19172248</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Missale</surname> <given-names>C.</given-names></name> <name><surname>Nash</surname> <given-names>S. R.</given-names></name> <name><surname>Robinson</surname> <given-names>S. W.</given-names></name> <name><surname>Jaber</surname> <given-names>M.</given-names></name> <name><surname>Caron</surname> <given-names>M. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Dopamine receptors: from structure to function</article-title>. <source>Physiol. Rev.</source> <volume>78</volume>, <fpage>189</fpage>&#x02013;<lpage>225</lpage>. <pub-id pub-id-type="pmid">9457173</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname> <given-names>D.</given-names></name> <name><surname>Bravo-Rivera</surname> <given-names>C.</given-names></name> <name><surname>Quirk</surname> <given-names>G. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Infralimbic D2 receptors are necessary for fear extinction and extinction-related tone responses</article-title>. <source>Biol. Psychiatry</source> <volume>68</volume>, <fpage>1055</fpage>&#x02013;<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2010.08.014</pub-id><pub-id pub-id-type="pmid">20926066</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname> <given-names>D.</given-names></name> <name><surname>Olivera-Figueroa</surname> <given-names>L. A.</given-names></name> <name><surname>Pine</surname> <given-names>D. S.</given-names></name> <name><surname>Quirk</surname> <given-names>G. J.</given-names></name></person-group> (<year>2009</year>). <article-title>The effects of yohimbine and amphetamine on fear expression and extinction in rats</article-title>. <source>Psychopharmacology</source> <volume>204</volume>, <fpage>599</fpage>&#x02013;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-009-1491-x</pub-id><pub-id pub-id-type="pmid">19242678</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nader</surname> <given-names>K.</given-names></name> <name><surname>LeDoux</surname> <given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>The dopaminergic modulation of fear: quinpirole impairs the recall of emotional memories in rats</article-title>. <source>Behav. Neurosci.</source> <volume>113</volume>, <fpage>152</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1037//0735-7044.113.1.152</pub-id><pub-id pub-id-type="pmid">10197915</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Donnell</surname> <given-names>P.</given-names></name></person-group> (<year>2010</year>). <article-title>Adolescent maturation of cortical dopamine</article-title>. <source>Neurotox. Res.</source> <volume>18</volume>, <fpage>306</fpage>&#x02013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-010-9157-3</pub-id><pub-id pub-id-type="pmid">20151241</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orsini</surname> <given-names>C. A.</given-names></name> <name><surname>Kim</surname> <given-names>J. H.</given-names></name> <name><surname>Knapska</surname> <given-names>E.</given-names></name> <name><surname>Maren</surname> <given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Hippocampal and prefrontal projections to the basal amygdala mediate contextual regulation of fear after extinction</article-title>. <source>J. Neurosci.</source> <volume>31</volume>, <fpage>17269</fpage>&#x02013;<lpage>17277</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4095-11.2011</pub-id><pub-id pub-id-type="pmid">22114293</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pattwell</surname> <given-names>S. S.</given-names></name> <name><surname>Duhoux</surname> <given-names>S.</given-names></name> <name><surname>Hartley</surname> <given-names>C. A.</given-names></name> <name><surname>Johnson</surname> <given-names>D. C.</given-names></name> <name><surname>Jing</surname> <given-names>D.</given-names></name> <name><surname>Elliott</surname> <given-names>M. D.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Altered fear learning across development in both mouse and human</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>109</volume>, <fpage>16318</fpage>&#x02013;<lpage>16323</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1206834109</pub-id><pub-id pub-id-type="pmid">22988092</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pattwell</surname> <given-names>S. S.</given-names></name> <name><surname>Lee</surname> <given-names>F. S.</given-names></name> <name><surname>Casey</surname> <given-names>B. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Fear learning and memory across adolescent development: hormones and behavior special issue: puberty and adolescence</article-title>. <source>Horm. Behav.</source> <volume>64</volume>, <fpage>380</fpage>&#x02013;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2013.01.016</pub-id><pub-id pub-id-type="pmid">23998679</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pattwell</surname> <given-names>S. S.</given-names></name> <name><surname>Liston</surname> <given-names>C.</given-names></name> <name><surname>Jing</surname> <given-names>D.</given-names></name> <name><surname>Ninan</surname> <given-names>I.</given-names></name> <name><surname>Yang</surname> <given-names>R. R.</given-names></name> <name><surname>Witztum</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Dynamic changes in neural circuitry during adolescence are associated with persistent attenuation of fear memories</article-title>. <source>Nat. Commun.</source> <volume>7</volume>:<fpage>11475</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms11475</pub-id><pub-id pub-id-type="pmid">27215672</pub-id></citation></ref>
<ref id="B64"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname> <given-names>G.</given-names></name> <name><surname>Watson</surname> <given-names>C.</given-names></name></person-group> (<year>1998</year>). <source>The Rat Brain Atlas in Stereotaxic Coordinates.</source> <publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname> <given-names>J.</given-names></name> <name><surname>Kalivas</surname> <given-names>P. W.</given-names></name> <name><surname>Quirk</surname> <given-names>G. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Extinction circuits for fear and addiction overlap in prefrontal cortex</article-title>. <source>Learn. Mem.</source> <volume>16</volume>, <fpage>279</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1101/lm.1041309</pub-id><pub-id pub-id-type="pmid">19380710</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname> <given-names>E. A.</given-names></name> <name><surname>Delgado</surname> <given-names>M. R.</given-names></name> <name><surname>Nearing</surname> <given-names>K. I.</given-names></name> <name><surname>LeDoux</surname> <given-names>J. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Extinction learning in humans: role of the amygdala and vmPFC</article-title>. <source>Neuron</source> <volume>43</volume>, <fpage>897</fpage>&#x02013;<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.08.042</pub-id><pub-id pub-id-type="pmid">15363399</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Polanczyk</surname> <given-names>G. V.</given-names></name> <name><surname>Salum</surname> <given-names>G. A.</given-names></name> <name><surname>Sugaya</surname> <given-names>L. S.</given-names></name> <name><surname>Caye</surname> <given-names>A.</given-names></name> <name><surname>Rohde</surname> <given-names>L. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Annual research review: a meta-analysis of the worldwide prevalence of mental disorders in children and adolescents</article-title>. <source>J. Child Psychol. Psychiatry</source> <volume>56</volume>, <fpage>345</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1111/jcpp.12381</pub-id><pub-id pub-id-type="pmid">25649325</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ponnusamy</surname> <given-names>R.</given-names></name> <name><surname>Nissim</surname> <given-names>H. A.</given-names></name> <name><surname>Barad</surname> <given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Systemic blockade of D2-like dopamine receptors facilitates extinction of conditioned fear in mice</article-title>. <source>Learn. Mem.</source> <volume>12</volume>, <fpage>399</fpage>&#x02013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1101/lm.96605</pub-id><pub-id pub-id-type="pmid">16077018</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quirk</surname> <given-names>G. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Memory for extinction of conditioned fear is long-lasting and persists following spontaneous recovery</article-title>. <source>Learn. Mem.</source> <volume>9</volume>, <fpage>402</fpage>&#x02013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1101/lm.49602</pub-id><pub-id pub-id-type="pmid">12464700</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quirk</surname> <given-names>G. J.</given-names></name> <name><surname>Russo</surname> <given-names>G. K.</given-names></name> <name><surname>Barron</surname> <given-names>J. L.</given-names></name> <name><surname>Lebron</surname> <given-names>K.</given-names></name></person-group> (<year>2000</year>). <article-title>The role of ventromedial prefrontal cortex in the recovery of extinguished fear</article-title>. <source>J. Neurosci.</source> <volume>20</volume>, <fpage>6225</fpage>&#x02013;<lpage>6231</lpage>. <pub-id pub-id-type="pmid">10934272</pub-id></citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname> <given-names>D. R.</given-names></name> <name><surname>Lewis</surname> <given-names>D. A.</given-names></name></person-group> (<year>1995</year>). <article-title>Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis</article-title>. <source>J. Comp. Neurol.</source> <volume>358</volume>, <fpage>383</fpage>&#x02013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903580306</pub-id><pub-id pub-id-type="pmid">7560293</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rothmond</surname> <given-names>D. A.</given-names></name> <name><surname>Weickert</surname> <given-names>C. S.</given-names></name> <name><surname>Webster</surname> <given-names>M. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Developmental changes in human dopamine neurotransmission: cortical receptors and terminators</article-title>. <source>BMC Neurosci.</source> <volume>13</volume>:<fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2202-13-18</pub-id><pub-id pub-id-type="pmid">22336227</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rozen</surname> <given-names>S.</given-names></name> <name><surname>Skaletsky</surname> <given-names>H.</given-names></name></person-group> (<year>2000</year>). <article-title>Primer3 on the WWW for general users and for biologist programmers</article-title>. <source>Methods Mol. Biol.</source> <volume>132</volume>, <fpage>365</fpage>&#x02013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1385/1-59259-192-2:365</pub-id><pub-id pub-id-type="pmid">10547847</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seamans</surname> <given-names>J. K.</given-names></name> <name><surname>Yang</surname> <given-names>C. R.</given-names></name></person-group> (<year>2004</year>). <article-title>The principal features and mechanisms of dopamine modulation in the prefrontal cortex</article-title>. <source>Prog. Neurobiol.</source> <volume>74</volume>, <fpage>1</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2004.05.006</pub-id><pub-id pub-id-type="pmid">15381316</pub-id></citation></ref>
<ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sesack</surname> <given-names>S. R.</given-names></name> <name><surname>Aoki</surname> <given-names>C.</given-names></name> <name><surname>Pickel</surname> <given-names>V. M.</given-names></name></person-group> (<year>1994</year>). <article-title>Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets</article-title>. <source>J. Neurosci.</source> <volume>14</volume>, <fpage>88</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="pmid">7904306</pub-id></citation></ref>
<ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sierra-Mercado</surname> <given-names>D.</given-names></name> <name><surname>Padilla-Coreano</surname> <given-names>N.</given-names></name> <name><surname>Quirk</surname> <given-names>G. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus and basolateral amygdala in the expression and extinction of conditioned fear</article-title>. <source>Neuropsychopharmacology</source> <volume>36</volume>, <fpage>529</fpage>&#x02013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2010.184</pub-id><pub-id pub-id-type="pmid">20962768</pub-id></citation></ref>
<ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Somerville</surname> <given-names>L. H.</given-names></name> <name><surname>Jones</surname> <given-names>R. M.</given-names></name> <name><surname>Casey</surname> <given-names>B. J.</given-names></name></person-group> (<year>2010</year>). <article-title>A time of change: behavioral and neural correlates of adolescent sensitivity to appetitive and aversive environmental cues</article-title>. <source>Brain Cogn.</source> <volume>72</volume>, <fpage>124</fpage>&#x02013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.bandc.2009.07.003</pub-id><pub-id pub-id-type="pmid">19695759</pub-id></citation></ref>
<ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Southam-Gerow</surname> <given-names>M. A.</given-names></name> <name><surname>Kendall</surname> <given-names>P. C.</given-names></name> <name><surname>Weersing</surname> <given-names>V. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Examining outcome variability: correlates of treatment response in a child and adolescent anxiety clinic</article-title>. <source>J. Clin. Child Psychol.</source> <volume>30</volume>, <fpage>422</fpage>&#x02013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1207/S15374424JCCP3003_13</pub-id><pub-id pub-id-type="pmid">11501258</pub-id></citation></ref>
<ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spear</surname> <given-names>L. P.</given-names></name></person-group> (<year>2000</year>). <article-title>The adolescent brain and age-related behavioral manifestations</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>24</volume>, <fpage>417</fpage>&#x02013;<lpage>463</lpage>. <pub-id pub-id-type="doi">10.1016/s0149-7634(00)00014-2</pub-id><pub-id pub-id-type="pmid">10817843</pub-id></citation></ref>
<ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tarazi</surname> <given-names>F. I.</given-names></name> <name><surname>Baldessarini</surname> <given-names>R. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Comparative postnatal development of dopamine D(1), D(2) and D(4) receptors in rat forebrain</article-title>. <source>Int. J. Dev. Neurosci.</source> <volume>18</volume>, <fpage>29</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/s0736-5748(99)00108-2</pub-id><pub-id pub-id-type="pmid">10708903</pub-id></citation></ref>
<ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tarazi</surname> <given-names>F. I.</given-names></name> <name><surname>Tomasini</surname> <given-names>E. C.</given-names></name> <name><surname>Baldessarini</surname> <given-names>R. J.</given-names></name></person-group> (<year>1998</year>). <article-title>Postnatal development of dopamine D4-like receptors in rat forebrain regions: comparison with D2-like receptors</article-title>. <source>Dev. Brain Res.</source> <volume>110</volume>, <fpage>227</fpage>&#x02013;<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-3806(98)00111-4</pub-id><pub-id pub-id-type="pmid">9748595</pub-id></citation></ref>
<ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tarazi</surname> <given-names>F. I.</given-names></name> <name><surname>Tomasini</surname> <given-names>E. C.</given-names></name> <name><surname>Baldessarini</surname> <given-names>R. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Postnatal development of dopamine D1-like receptors in rat cortical and striatolimbic brain regions: an autoradiographic study</article-title>. <source>Dev. Neurosci.</source> <volume>21</volume>, <fpage>43</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1159/000017365</pub-id><pub-id pub-id-type="pmid">10077701</pub-id></citation></ref>
<ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname> <given-names>K. Y.</given-names></name> <name><surname>O&#x02019;Donnell</surname> <given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>D2 dopamine receptors recruit a GABA component for their attenuation of excitatory synaptic transmission in the adult rat prefrontal cortex</article-title>. <source>Synapse</source> <volume>61</volume>, <fpage>843</fpage>&#x02013;<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20432</pub-id><pub-id pub-id-type="pmid">17603809</pub-id></citation></ref>
<ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname> <given-names>S. L.</given-names></name> <name><surname>Khan</surname> <given-names>Y.</given-names></name> <name><surname>Benes</surname> <given-names>F. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Cellular distribution of dopamine D1 and D2 receptors in rat medial prefrontal cortex</article-title>. <source>J. Neurosci.</source> <volume>13</volume>, <fpage>2551</fpage>&#x02013;<lpage>2564</lpage>. <pub-id pub-id-type="pmid">8501521</pub-id></citation></ref>
<ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wahlstrom</surname> <given-names>D.</given-names></name> <name><surname>White</surname> <given-names>T.</given-names></name> <name><surname>Luciana</surname> <given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>Neurobehavioral evidence for changes in dopamine system activity during adolescence</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>34</volume>, <fpage>631</fpage>&#x02013;<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2009.12.007</pub-id><pub-id pub-id-type="pmid">20026110</pub-id></citation></ref>
<ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weickert</surname> <given-names>C. S.</given-names></name> <name><surname>Webster</surname> <given-names>M. J.</given-names></name> <name><surname>Gondipalli</surname> <given-names>P.</given-names></name> <name><surname>Rothmond</surname> <given-names>D.</given-names></name> <name><surname>Fatula</surname> <given-names>R. J.</given-names></name> <name><surname>Herman</surname> <given-names>M. M.</given-names></name> <etal/></person-group>. (<year>2007</year>). <article-title>Postnatal alterations in dopaminergic markers in the human prefrontal cortex</article-title>. <source>Neuroscience</source> <volume>144</volume>, <fpage>1109</fpage>&#x02013;<lpage>1119</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.10.009</pub-id><pub-id pub-id-type="pmid">17123740</pub-id></citation></ref>
<ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiner</surname> <given-names>D. M.</given-names></name> <name><surname>Levey</surname> <given-names>A. I.</given-names></name> <name><surname>Sunahara</surname> <given-names>R. K.</given-names></name> <name><surname>Niznik</surname> <given-names>H. B.</given-names></name> <name><surname>O&#x02019;Dowd</surname> <given-names>B. F.</given-names></name> <name><surname>Seeman</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>1991</year>). <article-title>D1 and D2 dopamine receptor mRNA in rat brain</article-title>. <source>Proc. Natl. Acad. Sci. U S A</source> <volume>88</volume>, <fpage>1859</fpage>&#x02013;<lpage>1863</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.88.5.1859</pub-id><pub-id pub-id-type="pmid">1825729</pub-id></citation></ref>
<ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zbukvic</surname> <given-names>I. C.</given-names></name> <name><surname>Ganella</surname> <given-names>D. E.</given-names></name> <name><surname>Perry</surname> <given-names>C. J.</given-names></name> <name><surname>Madsen</surname> <given-names>H. B.</given-names></name> <name><surname>Bye</surname> <given-names>C. R.</given-names></name> <name><surname>Lawrence</surname> <given-names>A. J.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Role of dopamine 2 receptor in impaired drug-cue extinction in adolescent rats</article-title>. <source>Cereb. Cortex</source> <volume>26</volume>, <fpage>2895</fpage>&#x02013;<lpage>2904</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhw051</pub-id><pub-id pub-id-type="pmid">26946126</pub-id></citation></ref>
</ref-list>
</back>
</article>